Instil’s

instil’s-stock-sinks-after-it-clears-out-pipeline,-hands-2-drugs-back-to-immuneonco

Biotechnology Instil's Uncategorized

Instil’s stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco

Jan 6, 2026

Instil Bio’s hopes for its refreshed clinical pipeline appear to have ended in failure, with...

instil’s-licensed-pd-l1xvegf-bispecific-shows-promise-in-china,-instilling-hope-for-upcoming-us-test

Biotechnology Instil's Uncategorized

Instil’s licensed PD-L1xVEGF bispecific shows promise in China, instilling hope for upcoming US test

Jul 31, 2025

A PD-L1xVEGF bispecific antibody from China’s ImmuneOnco Biopharmaceuticals has shown early promise in shrinking lung...